Gene · 1633
Papers2,658
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,658
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Chromosomal Heterogeneity and Enrichment of Mitotic Regulatory Programs Reveal a Therapeutic Vulnerability in Cytarabine-Resistant FLT3-ITD AML. | Curr Issues Mol Biol | 2026 | 42793322 | PubTator, text mining | PubMed |
| A complex mutational signature generated by cytarabine resistance. | NAR Cancer | 2026 | 42630438 | PubTator, text mining | PubMed |
| Folic acid alleviates neuroinflammation after intracerebral hemorrhage by epigenetically regulating the AMPD2/DCK/NF-κB pathway. | Phytomedicine | 2026 | 42542053 | PubTator, text mining | PubMed |
| Metabolic and Molecular Mechanisms of Gemcitabine Resistance in Urothelial Carcinoma. | Cancers (Basel) | 2026 | 42449668 | PubTator, text mining | PubMed |
| Cellular pharmacology of fludarabine: molecular determinants of transport and metabolism. | Front Pharmacol | 2026 | 42239518 | PubTator, text mining | PubMed |
| Pharmacogenomic profiling of the efficacy of gemcitabine monotherapy in metastatic pancreatic cancer: Subgroup analysis of the GENESECT study. | Br J Clin Pharmacol | 2026 | 42220058 | PubTator, text mining | PubMed |
| Epigenetic Biomarkers for Predicting Nucleoside Analog Drug Response and Resistance in Cancer. | Biomolecules | 2026 | 42072708 | PubTator, text mining | PubMed |
| Marine Bioactive Compounds from Functional Seafoods: Pharmacological Mechanisms and Health Applications. | Mar Drugs | 2026 | 41892975 | PubTator, text mining | PubMed |
| Deoxycytidine kinase inhibition: Rewiring tumor nucleotide metabolism for therapeutic gain. | Nucleosides Nucleotides Nucleic Acids | 2026 | 41889017 | PubTator, text mining | PubMed |
| Research progress of plant-derived chemical compounds for overcoming pancreatic cancer drug resistance. | World J Gastroenterol | 2026 | 41810441 | PubTator, text mining | PubMed |
| Globo H ceramide confers chemoresistance and poor prognosis to advanced gallbladder cancer via A2AR/cAMP/PKA pathway. | Theranostics | 2026 | 41799195 | PubTator, text mining | PubMed |
| Exploring the gut microbiome and metabolomic interactions of antimetabolite drugs to optimize therapy. | Gut Microbes | 2026 | 41758194 | PubTator, text mining | PubMed |
| Sensitising PDAC to Gemcitabine by Suppressing NF-κB Pathway and Enhancing Apoptosis. | Pharmaceuticals (Basel) | 2026 | 41754784 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Immune-Related Mitochondrial Genes in Ischemic Stroke Through Integrated Bioinformatics and Validation. | Biomedicines | 2026 | 41751274 | PubTator, text mining | PubMed |
| Targeting FN1 to overcome gemcitabine resistance in gallbladder cancer: Mechanistic insights and an iRGD-modified PEG-PLGA nanoparticle delivery strategy. | Mater Today Bio | 2026 | 41732388 | PubTator, text mining | PubMed |
| Physiologically Based Pharmacokinetic Virtual Twin Approach for Fludarabine Dosing in Pediatric Hematopoietic Stem Cell Transplantation. | CPT Pharmacometrics Syst Pharmacol | 2026 | 41709524 | PubTator, text mining | PubMed |
| Integrin β1 Demarks Precursors of Brain-Residing Antibody-Secreting Cells in Multiple Sclerosis. | Neurol Neuroimmunol Neuroinflamm | 2026 | 41698162 | PubTator, text mining | PubMed |
| Expanding the payload scope in antibody-drug conjugates by delivery of hydroxy-containing drugs through self-immolative phosphoramidates. | Nat Commun | 2026 | 41554755 | PubTator, text mining | PubMed |
| Quantifying and comparing causal patterns in stochastic chemical reaction networks. | NPJ Syst Biol Appl | 2026 | 41507217 | PubTator, text mining | PubMed |
| Noninvasive in vivo deoxycytidine kinase (dCK)-PET identifies tumor-draining lymph nodes upon immune checkpoint inhibitor therapy. | Npj Imaging | 2026 | 41495426 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1633/papers